Vizient has ranked Rush University Medical Center #1 for quality among the nation’s most prestigious academic medical centers. Learn more.

Excellence is just the beginning.


French German Italian Portuguese Russian

Treatment Study for Subjects with Severe Hemophilia A or B

Clinical Trial Title: 
A multicenter, open-label, multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of subcutaneous and/or intravenous PF-06741086 in subjects with severe hemophilia A or B.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Lisa Boggio, MD
Clinical Trial Protocol Description: 

Nineteen office clinic visits over 5 months.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are age 18-64 years old.
  • Have hemophilia A or B.
  • Have had 6 bleeds within 6 months.
  • Have on demand (PRN) factor usage.

This is a partial list of elgibility requirements.

Clinical Trial Area: 
Blood Disorders and Hematologic Cancers
Contact Phone: 
(312) 942-3034
Contact Name: 
Lisa Boggio, MD